ArticleBMJ open2018

LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence.

Nadine Ezard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.